KRO Latest Report

DataVisFriday, Mar 7, 2025 3:22 am ET

1min read

Performance of the Current Report

KRO's total operating revenue was RMB423.1 million as of December 31, 2024, up 5.00% from RMB400.1 million as of December 31, 2023. This growth reflects the company's improvement in operating revenue, demonstrating its enhanced competitiveness and sales capacity in the market.

Key Data in the Financial Report

1. The total operating revenue in 2024 was RMB423.1 million, up RMB23 million from RMB400.1 million in 2023, with a growth rate of 5.00%.

2. The recovery of market demand may be one of the key factors driving revenue growth, indicating a favorable economic environment.

3. The company implemented optimized sales strategies, enhancing the market competitiveness of its products and attracting more customers.

4. In 2024, Konnos launched several new products, such as the upgrade of electrical stimulation products and the new generation of high-end transcranial magnetic devices MagNeuro ONE, further boosting sales.

5. The expansion of the customer base, possibly through market expansion or customer relationship management, promoted revenue growth.

Peer Comparison

1. Industry-wide analysis: The industry in which Konnos operates shows signs of recovery, with an improved overall market environment, and most peer companies reported growth in operating revenue. The improvement in overall operating revenue was significant due to the rise in market demand.

2. Peer evaluation analysis: Konnos' operating revenue growth rate of 5.00% is outstanding compared to 12.93% for TED and 0.79% for Jinpan Technology. Konnos' growth rate is significantly higher than these companies, indicating its competitiveness in the market.

Summary

Konnos' revenue growth in 2024 benefited from the recovery of market demand, optimized sales strategies, and the launch of new products. Compared to other companies in the industry, its growth rate is faster, indicating a strong competitive position in the market.

Opportunities

1. Continuously launching new products, especially in the fields of electrical stimulation and electrophysiology, may further enhance market share.

2. Optimizing and enhancing the quality of distributors can help strengthen the brand's influence among end consumers, promoting sales growth.

3. The company can further expand its customer base and sales channels with the recovery of the industry and increased market demand.

Risks

1. Intensified competition may lead to price wars, affecting the company's profit margin.

2. If market demand fails to continue growing, it may have a negative impact on future operating revenue.

3. If the market acceptance of new products is lower than expected, it may result in insufficient returns on research and development investment.

Disclaimer: the above is a summary showing certain market information. AInvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.